Bridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Policy, in Venice, Italy, on 25 October, 2008.

Hdl Handle:
http://hdl.handle.net/10147/253496
Title:
Bridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Policy, in Venice, Italy, on 25 October, 2008.
Authors:
Atella, V; Brady, A; Catapano, A L; Critchley, J; Graham, I M; Hobbs, F D R; Leal, J; Lindgren, P; Vanuzzo, D; Volpe, M; Wood, D; Paoletti, R
Affiliation:
Department of Economics, University of Rome Tor Vergata, Rome, Italy.
Citation:
Bridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Policy, in Venice, Italy, on 25 October, 2008. 2009, 10 (1):3-21 Atheroscler Suppl
Publisher:
Atherosclerosis. Supplements
Journal:
Atherosclerosis. Supplements
Issue Date:
10-Jun-2009
URI:
http://hdl.handle.net/10147/253496
DOI:
10.1016/S1567-5688(09)70003-0
PubMed ID:
19497553
Abstract:
In Europe, cardiovascular disease (CVD) represents the main cause of morbidity and mortality, costing countries euro 190 billion yearly (2006). CVD prevention remains unsatisfactory across Europe largely due to poor control of CVD risk factors (RFs), growing incidence of obesity and diabetes, and sedentary lifestyle/poor dietary habits. Hypercholesterolaemia is a proven CVD RF, and LDL-C lowering slows atherosclerotic progression and reduces major coronary events. Lipid-lowering therapy is cost-effective, and intensive treatment of high-risk patients further improves cost effectiveness. In Italy, models indicate that improved cholesterol management translates into potential yearly savings of euro 2.9-4 billion. Identifying and eliminating legislative and administrative barriers is essential to providing optimal lipid care to high-risk patients. Public health and government policy can influence clinical practice rapidly, and guideline endorsement via national health policy may reduce the CVD burden and change physician and patient behaviour. Action to reduce CVD burden should ideally include the integration of strategies to lower the incidence of major CV events, improvement in total CV risk estimation, database monitoring of CVD trends, and development of population educational initiatives on CVD prevention. Failure to bridge the gap between science and health policy, particularly in relation to lipid management, could result in missed opportunities to reverse the burgeoning epidemic of CVD in Europe.
Item Type:
Article
Language:
en
MeSH:
Cardiovascular Diseases; Cost of Illness; Europe; Government; Health Policy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipid Metabolism; Preventive Medicine; Public Health; Risk Factors; Science; World Health
ISSN:
1878-5050

Full metadata record

DC FieldValue Language
dc.contributor.authorAtella, Ven_GB
dc.contributor.authorBrady, Aen_GB
dc.contributor.authorCatapano, A Len_GB
dc.contributor.authorCritchley, Jen_GB
dc.contributor.authorGraham, I Men_GB
dc.contributor.authorHobbs, F D Ren_GB
dc.contributor.authorLeal, Jen_GB
dc.contributor.authorLindgren, Pen_GB
dc.contributor.authorVanuzzo, Den_GB
dc.contributor.authorVolpe, Men_GB
dc.contributor.authorWood, Den_GB
dc.contributor.authorPaoletti, Ren_GB
dc.date.accessioned2012-11-27T15:35:33Z-
dc.date.available2012-11-27T15:35:33Z-
dc.date.issued2009-06-10-
dc.identifier.citationBridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Policy, in Venice, Italy, on 25 October, 2008. 2009, 10 (1):3-21 Atheroscler Supplen_GB
dc.identifier.issn1878-5050-
dc.identifier.pmid19497553-
dc.identifier.doi10.1016/S1567-5688(09)70003-0-
dc.identifier.urihttp://hdl.handle.net/10147/253496-
dc.description.abstractIn Europe, cardiovascular disease (CVD) represents the main cause of morbidity and mortality, costing countries euro 190 billion yearly (2006). CVD prevention remains unsatisfactory across Europe largely due to poor control of CVD risk factors (RFs), growing incidence of obesity and diabetes, and sedentary lifestyle/poor dietary habits. Hypercholesterolaemia is a proven CVD RF, and LDL-C lowering slows atherosclerotic progression and reduces major coronary events. Lipid-lowering therapy is cost-effective, and intensive treatment of high-risk patients further improves cost effectiveness. In Italy, models indicate that improved cholesterol management translates into potential yearly savings of euro 2.9-4 billion. Identifying and eliminating legislative and administrative barriers is essential to providing optimal lipid care to high-risk patients. Public health and government policy can influence clinical practice rapidly, and guideline endorsement via national health policy may reduce the CVD burden and change physician and patient behaviour. Action to reduce CVD burden should ideally include the integration of strategies to lower the incidence of major CV events, improvement in total CV risk estimation, database monitoring of CVD trends, and development of population educational initiatives on CVD prevention. Failure to bridge the gap between science and health policy, particularly in relation to lipid management, could result in missed opportunities to reverse the burgeoning epidemic of CVD in Europe.en_GB
dc.language.isoenen
dc.publisherAtherosclerosis. Supplementsen_GB
dc.rightsArchived with thanks to Atherosclerosis. Supplementsen_GB
dc.subject.meshCardiovascular Diseases-
dc.subject.meshCost of Illness-
dc.subject.meshEurope-
dc.subject.meshGovernment-
dc.subject.meshHealth Policy-
dc.subject.meshHumans-
dc.subject.meshHydroxymethylglutaryl-CoA Reductase Inhibitors-
dc.subject.meshHypolipidemic Agents-
dc.subject.meshLipid Metabolism-
dc.subject.meshPreventive Medicine-
dc.subject.meshPublic Health-
dc.subject.meshRisk Factors-
dc.subject.meshScience-
dc.subject.meshWorld Health-
dc.titleBridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Policy, in Venice, Italy, on 25 October, 2008.en_GB
dc.typeArticleen
dc.contributor.departmentDepartment of Economics, University of Rome Tor Vergata, Rome, Italy.en_GB
dc.identifier.journalAtherosclerosis. Supplementsen_GB
dc.description.provinceLeinsteren
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.